Glenmark Pharma at ₹2,270: Chartists Eye ₹2,500

Glenmark Pharmaceuticals shares were at ₹2,270 on July 7, after chartists pointed to a completed corrective phase and the start of a fresh uptrend.

The stock built a base above ₹2,150. A strong trendline supported the recent rise. Chartists said the pattern suggested the corrective fall had ended and a new leg of the upmove had begun.

A support cluster in the ₹2,220–₹2,180 region provided a zone for fresh buyers to limit downside, they added. The immediate target for the current move was ₹2,500 in the coming week.

A close below ₹2,150 would invalidate the bullish setup, chartists said. Glenmark closed at ₹2,270.